MYB and breast carcinoma: However, there is little known about the role of c-Myb in normal mammopoeisis and breast tumorigenesis, despite its high expression in virtually all ER+ tumors as well as in 29% of hereditary (typically ER-negative) BRCA1 breast cancers [17], [18].